Medite Cancer Diagnostics, Inc. (MDIT)

Medite Cancer Diagnostics Revenue

Medite Cancer Diagnostics had revenue of $2.39M in the quarter ending September 30, 2018, with 41.99% growth. This brings the company's total for the last twelve months to $8.13M, up 19.50% year-over-year. In the year 2017, Medite Cancer Diagnostics had annual revenue of $6.81M, down -26.25%. That makes Medite Cancer Diagnostics the 38,222nd largest company in the world by revenue and 5,018th in the United States.

• Revenue (ttm): 8.13M
• Revenue Growth: +19.50%
• P/S Ratio: 0.00
• Revenue / Employee: 117.87K
• Employees: 69
• Market Cap: 8.58K

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Germany 5.87M 86.2%
• United States 699.00K 10.3%
• Poland 241.00K 3.5%

Fiscal year ended Dec 31, 2017

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2017	6.81M	-2.43M	-26.25%
Dec 31, 2016	9.24M	-649.00K	-6.56%
Dec 31, 2015	9.89M	-1.10M	-9.98%
Dec 31, 2014	10.98M	1.03M	10.29%
Dec 31, 2013	9.96M	403.00K	4.22%

Data Source: S&P Global Market Intelligence Last updated: Nov 14, 2018

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 28, 2026

Data Sources Report a data error